Home / Drug shortages / Ceftazidime Injection

Ceftazidime Injection — FDA Drug Shortage

To Be Discontinued — Hospira, Inc., a Pfizer Company

The FDA lists a drug shortage record for Ceftazidime Injection (injection) from Hospira, Inc., a Pfizer Company with status To Be Discontinued. The shortage was first posted on 11/14/2025.

Shortage Details

Status
To Be Discontinued
Company
Hospira, Inc., a Pfizer Company
Package NDC
0409-5092-16
Dosage Form
Injection
Presentation
Tazicef, Injection, 1 g (NDC 0409-5092-16)
Initial Posting
11/14/2025
Revised Date

FDA data resources